{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-20T08:03:29.8409+00:00","published_at":"2026-10-20T04:46:52.66566+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:6b1n201443jpi","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:allan-d-kirk-m-d-ph-d-facs","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"Allan D. Kirk, M.D., Ph.D., FACS seat on Eledon Pharmaceuticals, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1d7csgu1pmxl40","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:james-robinson","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"James Robinson seat on Eledon Pharmaceuticals, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1dy3v0krgdf2c","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:committee:eledon-pharmaceuticals-inc:audit-compensation-chair","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"Audit; Compensation · Chair committee of Eledon Pharmaceuticals, Inc., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:11mph0b1mnil5","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:james-robinson","alpha:committee:eledon-pharmaceuticals-inc:audit-compensation-chair"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"James Robinson member of Audit; Compensation · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ppx19g1jwwqf6","event_type":"DIRECTOR_APPOINTED","effective_at":"2021-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:jan-hillson-m-d","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"Jan Hillson, M.D. seat on Eledon Pharmaceuticals, Inc., effective 2021-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:112u0oq1di20e","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:david-alexandre-c-gros-m-d","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"David-Alexandre C. Gros, M.D. seat on Eledon Pharmaceuticals, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1pxp5udi070j1","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:june-lee-m-d","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"June Lee, M.D. seat on Eledon Pharmaceuticals, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1a03h8j137qpqz","event_type":"DIRECTOR_APPOINTED","effective_at":"2020-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:steven-perrin-ph-d","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:14"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"Steven Perrin, Ph.D. seat on Eledon Pharmaceuticals, Inc., effective 2020-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4ad7lisb38ui","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:john-s-mcbride","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"John S. McBride seat on Eledon Pharmaceuticals, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1dqsgkbnw5zk","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:keith-a-katkin","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"Keith A. Katkin seat on Eledon Pharmaceuticals, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:imsq8q1wm6a22","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:committee:eledon-pharmaceuticals-inc:audit-chair-compensation","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"Audit · Chair; Compensation committee of Eledon Pharmaceuticals, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:hkw8z51wvecwf","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:john-s-mcbride","alpha:committee:eledon-pharmaceuticals-inc:audit-chair-compensation"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"John S. McBride member of Audit · Chair; Compensation, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1hi46m6nu24x0","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:committee:eledon-pharmaceuticals-inc:nominating-and-governance-chair","alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"Nominating and Governance · Chair committee of Eledon Pharmaceuticals, Inc., effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1pcffm2zv3fsm","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-20T04:46:52.66566+00:00","subject_ids":["alpha:person:keith-a-katkin","alpha:committee:eledon-pharmaceuticals-inc:nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:13"],"evidence_ids":["alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d"],"summary":"Keith A. Katkin member of Nominating and Governance · Chair, effective 2017-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:7","subject_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:allan-d-kirk-m-d-ph-d-facs","object_label":"Allan D. Kirk, M.D., Ph.D., FACS","object_source_name_forms":[],"value":"Allan D. Kirk, M.D., Ph.D., FACS: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:allan-d-kirk-m-d-ph-d-facs","name":"Allan D. Kirk, M.D., Ph.D., FACS"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-20T04:46:52.66566+00:00","sources":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:8","subject_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:david-alexandre-c-gros-m-d","object_label":"David-Alexandre C. Gros, M.D.","object_source_name_forms":[],"value":"David-Alexandre C. Gros, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:david-alexandre-c-gros-m-d","name":"David-Alexandre C. Gros, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-20T04:46:52.66566+00:00","sources":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:9","subject_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-robinson","object_label":"James Robinson","object_source_name_forms":[],"value":"James Robinson: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-robinson","name":"James Robinson"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-20T04:46:52.66566+00:00","sources":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:10","subject_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:jan-hillson-m-d","object_label":"Jan Hillson, M.D.","object_source_name_forms":[],"value":"Jan Hillson, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:jan-hillson-m-d","name":"Jan Hillson, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-20T04:46:52.66566+00:00","sources":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:11","subject_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:john-s-mcbride","object_label":"John S. McBride","object_source_name_forms":[],"value":"John S. McBride: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:john-s-mcbride","name":"John S. McBride"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-20T04:46:52.66566+00:00","sources":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:12","subject_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:june-lee-m-d","object_label":"June Lee, M.D.","object_source_name_forms":[],"value":"June Lee, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:june-lee-m-d","name":"June Lee, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-20T04:46:52.66566+00:00","sources":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:13","subject_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:keith-a-katkin","object_label":"Keith A. Katkin","object_source_name_forms":[],"value":"Keith A. Katkin: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:keith-a-katkin","name":"Keith A. Katkin"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-20T04:46:52.66566+00:00","sources":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:9c84e695-b238-43e3-8559-a8c7fa2dba63:leadership_role:14","subject_id":"alpha:company:9c84e695-b238-43e3-8559-a8c7fa2dba63","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:steven-perrin-ph-d","object_label":"Steven Perrin, Ph.D.","object_source_name_forms":[],"value":"Steven Perrin, Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:steven-perrin-ph-d","name":"Steven Perrin, Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-20T04:46:52.66566+00:00","sources":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-29","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:e9c9c008e701686a8a8f2038ab3dcc366023c7cdde2a5c5d04c21cb4bb74854d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Eledon Pharmaceuticals, Inc. DEF 14A 2025-04-29","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000095017025060299/eldn-20250429.htm","source_date":"2025-04-29","retrieved_at":"2026-04-28T23:38:03.331+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.829,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.823,"cross_source_agreement":0.75,"temporal_completeness":0.615},"diagnostics":{"published_claims":22,"factual_claims":22,"claims_with_linked_evidence":22,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":13,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-20T04:46:52.66566+00:00","observed_at":"2026-10-20T04:46:52.66566+00:00","reviewed_at":"2026-10-20T04:46:52.66566+00:00","verified_at":"2026-10-20T04:46:52.66566+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":22,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/eledon-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/eledon-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}